Computational modeling of DLBCL predicts response to BH3-mimetics (2023)
Attributed to:
Therapeutic targeting of refractory/relapsed diffuse large B-cell lymphoma through systems biology
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.02.01.526592
Publication URI: http://dx.doi.org/10.1101/2023.02.01.526592
Type: Preprint